Your physician will create an integrated protocol tailored to your specific health goals
The most common of these include nausea, vomiting, diarrhea, abdominal pain, and constipation
It is characterized by high hospital costs, morbidity, and mortality, and it provokes a high hospitalization rate and inpatient mortality [376,377,378]
Modulates inflammatory pathways throughout the digestive system and body, reducing chronic inflammation markers while supporting balanced immune responses necessary for healing
Statistics by two-sided unpaired t-tests compared to sgControl cells (d-f, j-l)
A significant concern is that the most common adverse effects of GLP-1 agonistsnausea, vomiting, diarrhea, and abdominal painoverlap substantially with Crohn's disease symptoms